Report Company Directory

KADESTONE CAPITAL CORP

Kadimahstem Ltd

• Kadimastem Ltd: 1 director by SmartInsider
• DGAP-News: Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment by EQS Group AG
• DGAP-News: Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells by EQS Group AG
• DGAP-News: Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening by EQS Group AG
• DGAP-News: Kadimastem Expands R&D Program to Include Multiple Sclerosis by EQS Group AG
• DGAP-News: Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) from the Israeli Innovation Authority by EQS Group AG
• DGAP-News: Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel Innovation Authority by EQS Group AG
• DGAP-News: Kadimastem Raises $5 million In Private Placement by EQS Group AG
• DGAP-News: Kadimastem Raises NIS 16.1 million ($5 million) In Private Placement by EQS Group AG
• DGAP-News: Kadimastem Holds Successful Preliminary Meeting with the FDA (INTERACT) Regarding IsletRx for the Treatment of Diabetes by EQS Group AG

Kading Cos. S.A.

• Business Warrior Platform Demand Soars, Increases Subscribers by 20% in July and Launches Revenue Generating Marketplace by Newsfile Corp.
• Business Warrior and Chatmeter Reach Deal to Boost Small Business Growth by Newsfile Corp.
• 50 Million Shares Returned to Business Warrior's Common Stock Treasury by Newsfile Corp.
• Business Warrior Announces Q1 Financial Results Since Merger by Newsfile Corp.
• Business Warrior Sees 62% Subscriber Increase; Receives Industry Recognition For COVID-19 Response by Newsfile Corp.

Kadmon Holdings

• Biotechnology "Cessation of Coverage: Kadmon Holdings Inc" Merle by UBS AG
• KDMN | Dropping Coverage; Sanofi Completes Acquisition of KDMN by Raymond James
• Raymond James Afternoon Notes - AMED, CGNX, DRTT, IFRX, NMRK, PODD by Raymond James
• KDMN | 3Q21 Update: Acquisition Closing Soon; FWIW Rezurock Launch Is Crushing It by Raymond James
• US Biotechnology "Dr. Col’s weekly dose – The week ahead, what we’re..." by UBS AG
• Raymond James Afternoon Notes - KDMN, PHM by Raymond James
• First Read: Kadmon Holdings Inc "Kadmon enters merger agreement with Sanofi" by UBS AG
• Kadmon Holdings Inc "Downgrade to Neutral on Sanofi Acquisition" (Neutral) Merle by UBS AG
• KDMN | Bought by Sanofi; Downgrade to Market Perform by Raymond James
• Raymond James Morning Notes - ALRM, AVLR, AXON, CARG, CBIO, COLD, CORE, CVET, CWK, DRTT, ENV, EQR, IFRX, ITRI, LNG, MSI, NGM, NTLA, PCTY, QDEL, REGI, STWD, SWCH, VSAT, WCN, YETI by Raymond James

Kadokawa Corporation

• PSA Media & Entertainment: PSA's Rankings of Video Game Stocks After Another Tremendous Quarter by Pelham Smithers Associates Ltd
• Japan games & amusement sector: Monthly box office revenues - Aggregated estimates of May box office revenues by Nomura Research
• ゲーム・アミューズメント：月次興行収入 - 5月の月次興行収入を集計 by Nomura Research
• Expectations for global growth in books, anime, and game IP already priced in by Mizuho Securities
• 書籍・アニメ・ゲームIPのグローバル成長等に対する期待は株価に織り込み済みとみる by Mizuho Securities
• FY3/25 results: eyes on paper book costs; expect strong new/existing game sales by Mizuho Securities
• 26/3期は紙書籍での費用増等に留意。カタリストは新作・既存ゲームの好調な販売とみる by Mizuho Securities
• Game/IP Content: Earnings Outlook by UBS AG
• Anime industry in 2025 - Speaker series report by Nomura Research
• 「2025年のアニメビジネス」 - スピーカーシリーズ報告 by Nomura Research